Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$153.15 - $198.21 $88,827 - $114,961
-580 Reduced 21.62%
2,103 $347,000
Q4 2022

Feb 08, 2023

BUY
$136.25 - $165.56 $289,395 - $351,649
2,124 Added 379.96%
2,683 $423,000
Q3 2022

Oct 27, 2022

BUY
$149.44 - $188.1 $7,472 - $9,405
50 Added 9.82%
559 $84,000
Q2 2022

Aug 03, 2022

BUY
$161.4 - $229.7 $6,456 - $9,188
40 Added 8.53%
509 $84,000
Q1 2022

May 10, 2022

BUY
$203.51 - $247.46 $13,228 - $16,084
65 Added 16.09%
469 $104,000
Q4 2021

Jan 26, 2022

BUY
$220.96 - $247.44 $5,303 - $5,938
24 Added 6.32%
404 $96,000
Q3 2021

Nov 03, 2021

BUY
$186.8 - $260.0 $26,338 - $36,660
141 Added 59.0%
380 $89,000
Q2 2021

Aug 10, 2021

BUY
$190.83 - $215.73 $24,426 - $27,613
128 Added 115.32%
239 $49,000
Q1 2021

May 13, 2021

BUY
$197.58 - $222.54 $21,931 - $24,701
111 New
111 $23,000

Others Institutions Holding ICUI

About ICU MEDICAL INC


  • Ticker ICUI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 23,899,400
  • Market Cap $3.79B
  • Description
  • ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...
More about ICUI
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.